C WorldWide Group Holding A S Sells 18,128 Shares of Synopsys, Inc. (NASDAQ:SNPS)

C WorldWide Group Holding A S reduced its position in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 24.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 54,728 shares of the semiconductor company’s stock after selling 18,128 shares during the period. Synopsys makes up 0.4% of C WorldWide Group Holding A S’s portfolio, making the stock its 28th biggest holding. C WorldWide Group Holding A S’s holdings in Synopsys were worth $28,180,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Dohj LLC bought a new position in Synopsys in the 4th quarter worth about $338,000. Headlands Technologies LLC lifted its position in Synopsys by 300.6% during the fourth quarter. Headlands Technologies LLC now owns 7,135 shares of the semiconductor company’s stock valued at $3,674,000 after purchasing an additional 5,354 shares during the last quarter. Kovack Advisors Inc. grew its stake in Synopsys by 17.8% in the 4th quarter. Kovack Advisors Inc. now owns 1,024 shares of the semiconductor company’s stock worth $527,000 after buying an additional 155 shares in the last quarter. Motley Fool Asset Management LLC increased its holdings in shares of Synopsys by 5.5% in the 4th quarter. Motley Fool Asset Management LLC now owns 4,598 shares of the semiconductor company’s stock worth $2,368,000 after buying an additional 239 shares during the last quarter. Finally, Semanteon Capital Management LP purchased a new stake in shares of Synopsys during the 4th quarter valued at $1,161,000. Institutional investors own 85.47% of the company’s stock.

Insider Buying and Selling

In other Synopsys news, insider John F. Runkel, Jr. sold 1,219 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $583.95, for a total transaction of $711,835.05. Following the transaction, the insider now directly owns 26,780 shares of the company’s stock, valued at approximately $15,638,181. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Synopsys news, insider John F. Runkel, Jr. sold 1,219 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $583.95, for a total value of $711,835.05. Following the completion of the sale, the insider now directly owns 26,780 shares in the company, valued at $15,638,181. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Marc N. Casper bought 750 shares of Synopsys stock in a transaction on Monday, March 25th. The shares were purchased at an average price of $585.45 per share, for a total transaction of $439,087.50. Following the acquisition, the director now directly owns 1,736 shares in the company, valued at approximately $1,016,341.20. The disclosure for this purchase can be found here. Insiders sold 26,832 shares of company stock valued at $15,464,992 over the last quarter. 0.66% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Piper Sandler started coverage on shares of Synopsys in a report on Thursday, April 4th. They set an “overweight” rating and a $665.00 price objective for the company. Robert W. Baird upped their price objective on Synopsys from $624.00 to $640.00 and gave the stock an “outperform” rating in a report on Thursday, February 22nd. Needham & Company LLC reissued a “buy” rating and set a $660.00 price objective on shares of Synopsys in a report on Friday, March 22nd. StockNews.com upgraded Synopsys from a “hold” rating to a “buy” rating in a research report on Monday, March 18th. Finally, Rosenblatt Securities reiterated a “buy” rating and set a $615.00 price target on shares of Synopsys in a research report on Thursday, March 21st. Eleven investment analysts have rated the stock with a buy rating, According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $601.00.

View Our Latest Analysis on Synopsys

Synopsys Price Performance

Synopsys stock traded up $13.55 during trading hours on Friday, reaching $543.66. The stock had a trading volume of 997,562 shares, compared to its average volume of 908,153. The company has a fifty day simple moving average of $563.73 and a 200-day simple moving average of $535.97. Synopsys, Inc. has a 52 week low of $362.06 and a 52 week high of $629.38. The stock has a market cap of $82.91 billion, a PE ratio of 59.87, a PEG ratio of 3.10 and a beta of 1.06.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its earnings results on Wednesday, February 21st. The semiconductor company reported $3.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.43 by $0.13. Synopsys had a return on equity of 22.88% and a net margin of 22.96%. The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. During the same period last year, the firm earned $1.75 earnings per share. Synopsys’s quarterly revenue was up 21.1% on a year-over-year basis. Research analysts predict that Synopsys, Inc. will post 9.78 earnings per share for the current fiscal year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.